Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept for macular edema secondary to retinal vein occlusion (Phase II, single-arm, China)
CTR20131301Phase 2Completed
- Sponsor
- Chengdu Kanghong Biotechnology Co., Ltd.
- Start
- Apr 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of conbercept in Vein occlusion (RVO), sponsored by Chengdu Kanghong Biotechnology Co., Ltd.. Started Apr 2014; status: completed.
02
Drugs
conbercept
03
Conditions
Vein occlusion (RVO)
Beyond the preview
Go deeper on CTR20131301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131301.